Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder with Integrated Pelvic Fascial Structure-Sparing in Males with Bladder Cancer.
Urology journal./Urology jornal. · 10.11.2025 · 22 (5) · 237-243
DOI: 10.22037/uj.v22i.8450 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Urology journal./Urology jornal., erschienen am 10.11.2025. Verfasst von Xin Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Urinary Bladder Neoplasms, Cystectomy, Urinary Reservoirs, Continent. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
PURPOSE: To describe our integrated pelvic fascial structure-sparing (IPFSS) technique for robotic-assisted radical cystectomy (RARC) with intracorporeal orthotopic neobladder (ONB) reconstruction and to evaluate its impact on urinary continence and sexual function in male patients. METHODS: This retrospective observational study was conducted at a single high-volume center. Male bladder cancer patients who underwent IPFSS RARC with ONB were included. Demographic, clinical, and pathological data were collected. Functional outcomes were evaluated and compared with a cohort of patients who underwent conventional non-nerve-sparing RARC. RESULTS: Thirty-six patients were included in the IPFSS group and 42 in the conventional group. RARC with intracorporeal urinary diversion was successfully completed in all patients without open conversion. The mean total operative time was 387.9 minutes in the IPFSS group and 392.0 minutes in the conventional group (p = 0.465). At 3 months post-surgery, 30 patients (83%) in the IPFSS group achieved daytime continence (0-1 pads), compared to 14 patients (33%) in the conventional group. By 6 months, daytime continence increased to 35 patients (97%) in the IPFSS group, while 28 patients (67%) in the conventional group achieved similar results. At 6 months, 30 patients (83%) in the IPFSS group reported full potency with or without phosphodiesterase type 5 (PDE5) inhibitors, compared to only 3 patients (7%) in the conventional group. CONCLUSION: We present a feasible surgical technique for RARC that involves holistic preservation of the pelvic fascial architecture. This approach is associated with a rapid recovery of daytime continence and sexual function in male patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China.
- Department of Vascular Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Zitieren
APA
Xu, X., Liang, Z., Feng, Y., Qi, H., Wang, S., Xia, D., & Wang, P. (2025). Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder with Integrated Pelvic Fascial Structure-Sparing in Males with Bladder Cancer. Urology journal./Urology jornal., 22(5), 237-243. https://doi.org/10.22037/uj.v22i.8450
Vancouver
Xu X, Liang Z, Feng Y, Qi H, Wang S, Xia D, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder with Integrated Pelvic Fascial Structure-Sparing in Males with Bladder Cancer. Urology journal./Urology jornal.. 2025;22(5):237-243. doi:10.22037/uj.v22i.8450
BibTeX
@article{Xu2025,
author = {Xu, Xin and Liang, Zhen and Feng, Yanfei and Qi, Honggang and Wang, Shuo and Xia, Dan and Wang, Ping},
title = {Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder with Integrated Pelvic Fascial Structure-Sparing in Males with Bladder Cancer},
journal = {Urology journal./Urology jornal.},
year = {2025},
volume = {22},
number = {5},
pages = {237--243},
doi = {10.22037/uj.v22i.8450}
}
EUVIMED